Sign Out
Each single-use vial contains 50 mg of brentuximab vedotin.
Each mL contains 5 mg of brentuximab vedotin, after reconstitution.
Brentuximab vedotin is an antibody-drug conjugate composed of a CD30-directed monoclonal antibody (recombinant chimeric immunoglobulin G1 (IgG1), produced by recombinant DNA technology in Chinese Hamster ovary cells) that is covalently linked to the antimicrotubule agent monomethyl auristatin E (MMAE).
Excipients/Inactive Ingredients: Citric acid monohydrate, sodium citrate dihydrate, α,α-Trehalose dihydrate, polysorbate 80.
